TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Press Release: Sanofi completes acquisition of Vicebio

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Sanofi
Press Release: Sanofi completes acquisition of Vicebio

Sanofi has completed the acquisition of Vicebio Ltd, gaining an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (HMPV), expanding its vaccine development capabilities.

Insights
BROS   positive

Fastest-growing coffee chain, beat earnings for 11 consecutive quarters, 1,030% annual EPS growth, increasing institutional investor positions


SNY   positive

The acquisition expands Sanofi's vaccine pipeline and technological capabilities, adding a non-mRNA vaccine candidate and enhancing their position in respiratory vaccine development